28th – 30th March 2017

London, UK

Novotel London West

Pre-Conference Workshop

Leveraging Clinical Trial Design and Execution to Improve CDx Development and Outcomes

Time: 28th March 2017, 12.30 – 17.00


12.30                     Workshop Registration Opens


13.00                     Trends in Precision Medicine & Companion Diagnostics

                              Steve Anderson, PhD – Covance, Inc.    


13.45                     Key Considerations: Changing Regulatory Framework in the EU & Globally   

                              Seamus Kearney, BEng MSc – ARC Consulting (Ireland)               


14:45                     Break


15:00                    Optimizing CDx Clinical Trial Design, Recruitment / Enrollment & Execution

Suso Platero, PhD – Covance, Inc.


15:45                     Multiplexing Technologies & CDx: Proteomic & Genomic Approaches

Jim White, PhD – NanoString Technologies (UK)


16:15                     Panel: Challenges & Opportunities in Drug & Diagnostic Co-Development

Pharma, Dx & CRO perspectives to be presented


17.00                     Adjourn

If you are interested in joining the pre-conference workshop hosted by Covance, please email ben.carrington@hansonwade.com. If accepted, the workshop will be free to attend as part of your conference registration.

Workshop Moderator:

Dr. Steve Anderson, Chief Scientific Officer, Covance Inc

Speaker Faculty:

Steve Anderson, Chief Scientific Officer, Covance, Inc.

Flora Berisha, Associate Director, Companion Diagnostics, Daiichi Sankyo

Seamus Kearney, CEO & Principal Consultant, ARC Consulting  

Peter Kerr, Vice President, Companion Diagnostic Development, Almac Diagnostics 

Suso Platero, Executive Director, Immuno-Oncology & Precision Medicine Leader, Covance, Inc.

Jim White, Senior Manager, Field Application Scientist, Nanostring Technologies



Novotel London West
1 Shortlands, Hammersmith
W6 8DR